Hatch/Waxman Reform Hearings Urged By Governors Association
This article was originally published in The Tan Sheet
Executive Summary
Eight governors and an employer coalition are urging Congress to "close the loopholes" that allow brand name companies to use the 30-month Hatch/Waxman stay of approval provisions to delay generic launches
You may also be interested in...
McCain/Schumer Generic Drug Bill Would End 30-Month Stay Of Approval
The revised McCain/Schumer generic drug bill eliminates the automatic stay of approval under current patent challenge procedures.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands